Your browser doesn't support javascript.
loading
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Meslé, Margaux M I; Sinnathamby, Mary; Mook, Piers; Pebody, Richard; Lakhani, Anissa; Zambon, Maria; Popovici, Odette; Lazar, Mihaela; Ljubovic, Amela Dedeic; Vukmir, Nina Rodic; Altas, Ayse Basak; Avci, Emine; Luniewska, Katarzyna; Szymanski, Karol; Gargasiene, Greta; Muralyte, Svajune; Dziugyte, Ausra; Zahra, Graziella; Gonçalves, Ana Rita; Spedaliero, Tania; Fournier, Guillaume; Alvarez-Vaca, Daniel; Petrovic, Goranka; Tabain, Irena; Prosenc, Katarina; Socan, Maja; Protic, Jelena; Dimitrijevic, Dragana; Druc, Alina; Apostol, Mariana; Kalasnikova, Kate Karolina; Nikisins, Sergejs; Reiche, Janine; Cai, Wei; Meijer, Adam; Teirlinck, Anne; Larrauri, Amparo; Casas, Inmaculada; Enouf, Vincent; Vaux, Sophie; Lomholt, Frederikke Kristensen; Trebbien, Ramona; Jirincova, Helena; Sebestova, Helena; Rózsa, Mónika; Molnár, Zsuzsanna; Aspelund, Gudrun; Baldvinsdottir, Gudrun Erna; Cottrell, Simon; Moore, Catherine.
Afiliação
  • Meslé MMI; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
  • Sinnathamby M; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
  • Mook P; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
  • Pebody R; World Health Organization (WHO) Regional Office for Europe Copenhagen Denmark.
  • Lakhani A; UK Health Security Agency London UK.
  • Zambon M; UK Health Security Agency London UK.
  • Popovici O; National Institute of Public Health Bucharest Romania.
  • Lazar M; Cantacuzino National Military-Medical Institute for Research and Development Bucharest Romania.
  • Ljubovic AD; Clinical Center University of Sarajevo Sarajevo Bosnia and Herzegovina.
  • Vukmir NR; Public Health Institute of the Republic of Srpska Banja Luka Bosnia and Herzegovina.
  • Altas AB; Faculty of Medicine University of Banja Luka Banja Luka Bosnia and Herzegovina.
  • Avci E; General Directorate of Public Health Ankara Türkiye.
  • Luniewska K; General Directorate of Public Health Ankara Türkiye.
  • Szymanski K; National Research Institute Warsaw Poland.
  • Gargasiene G; National Research Institute Warsaw Poland.
  • Muralyte S; National Public Health Center under the Ministry of Health Vilnius Lithuania.
  • Dziugyte A; National Public Health Surveillance Laboratory Vilnius Lithuania.
  • Zahra G; Ministry for Health Regulation Pieta Malta.
  • Gonçalves AR; Ministry for Health Regulation Pieta Malta.
  • Spedaliero T; University of Geneva Hospitals Geneva Switzerland.
  • Fournier G; University of Geneva Hospitals Geneva Switzerland.
  • Alvarez-Vaca D; Laboratoire National de Santé Dudelange Luxembourg.
  • Petrovic G; Laboratoire National de Santé Dudelange Luxembourg.
  • Tabain I; Croatian Institute of Public Health Zagreb Croatia.
  • Prosenc K; Croatian Institute of Public Health Zagreb Croatia.
  • Socan M; National Laboratory of Health, Environment and Food Ljubljana Slovenia.
  • Protic J; National Institute of Public Health Ljubljana Slovenia.
  • Dimitrijevic D; Institute of Virology, Vaccines and Sera Torlak Belgrade Serbia.
  • Druc A; Institute of Public Health of Serbia Belgrade Serbia.
  • Apostol M; National Agency for Public Health Chisinau Republic of Moldova.
  • Kalasnikova KK; National Agency for Public Health Chisinau Republic of Moldova.
  • Nikisins S; Centre for Disease Prevention and Control Riga Latvia.
  • Reiche J; Riga East University Hospital Riga Latvia.
  • Cai W; Robert Koch Institute Berlin Germany.
  • Meijer A; Robert Koch Institute Berlin Germany.
  • Teirlinck A; Centre for Infectious Disease Control Bilthoven The Netherlands.
  • Larrauri A; Centre for Infectious Disease Control Bilthoven The Netherlands.
  • Casas I; Carlos III Health Institute Madrid Spain.
  • Enouf V; Carlos III Health Institute Madrid Spain.
  • Vaux S; Institut Pasteur Paris France.
  • Lomholt FK; Santé Publique France Saint-Maurice France.
  • Trebbien R; Statens Serum Institute Copenhagen Denmark.
  • Jirincova H; Statens Serum Institute Copenhagen Denmark.
  • Sebestova H; National Institute of Public Health Prague Czechia.
  • Rózsa M; National Institute of Public Health Prague Czechia.
  • Molnár Z; National Public Health Center Budapest Hungary.
  • Aspelund G; National Public Health Center Budapest Hungary.
  • Baldvinsdottir GE; The Directorate of Health Reykjavik Iceland.
  • Cottrell S; The National University Hospital of Iceland Reykjavik Iceland.
  • Moore C; Public Health Wales Cardiff UK.
Influenza Other Respir Viruses ; 17(11): e13219, 2023 Nov.
Article em En | MEDLINE | ID: mdl-38025589
ABSTRACT

Background:

The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in early 2020 and subsequent implementation of public health and social measures (PHSM) disrupted the epidemiology of respiratory viruses. This work describes the epidemiology of respiratory syncytial virus (RSV) observed during two winter seasons (weeks 40-20) and inter-seasonal periods (weeks 21-39) during the pandemic between October 2020 and September 2022.

Methods:

Using data submitted to The European Surveillance System (TESSy) by countries or territories in the World Health Organization (WHO) European Region between weeks 40/2020 and 39/2022, we aggregated country-specific weekly RSV counts of sentinel, non-sentinel and Severe Acute Respiratory Infection (SARI) surveillance specimens and calculated percentage positivity. Results for both 2020/21 and 2021/22 seasons and inter-seasons were compared with pre-pandemic 2016/17 to 2019/20 seasons and inter-seasons.

Results:

Although more specimens were tested than in pre-COVID-19 pandemic seasons, very few RSV detections were reported during the 2020/21 season in all surveillance systems. During the 2021 inter-season, a gradual increase in detections was observed in all systems. In 2021/22, all systems saw early peaks of RSV infection, and during the 2022 inter-seasonal period, patterns of detections were closer to those seen before the COVID-19 pandemic.

Conclusion:

RSV surveillance continued throughout the COVID-19 pandemic, with an initial reduction in transmission, followed by very high and out-of-season RSV circulation (summer 2021) and then an early start of the 2021/22 season. As of the 2022/23 season, RSV circulation had not yet normalised.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / COVID-19 Limite: Humans Idioma: En Revista: Influenza Other Respir Viruses Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vírus Sincicial Respiratório Humano / Infecções por Vírus Respiratório Sincicial / COVID-19 Limite: Humans Idioma: En Revista: Influenza Other Respir Viruses Ano de publicação: 2023 Tipo de documento: Article